The genitourinary pathology society update on classification and grading of flat and papillary urothelial neoplasia with new reporting recommendations and approach …

MB Amin, E Comperat, JI Epstein, LD True… - Advances in anatomic …, 2021 - journals.lww.com
Abstract The Genitourinary Pathology Society (GUPS) undertook a critical review of the
recent advances in bladder neoplasia with a focus on issues relevant to the practicing …

Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management

L Cheng, S Zhang, M Wang, A Lopez-Beltran - Human Pathology, 2023 - Elsevier
The telomerase reverse transcriptase (TERT) promoter mutations are associated with
increased TERT mRNA and TERT protein levels, telomerase activity, and shorter but stable …

Glandular lesions of the urinary bladder: diagnostic and molecular updates

H Reis, GP Paner - Advances in Anatomic Pathology, 2024 - journals.lww.com
Glandular lesions in the urinary tract or their associated pathologies can pose a diagnostic
challenge. There is a variety of benign alterations and tumor types that need to be taken into …

[HTML][HTML] Circulating cell-free DNA in renal cell carcinoma: the new era of precision medicine

E Francini, GN Fanelli, F Pederzoli, S Spisak… - Cancers, 2022 - mdpi.com
Simple Summary Early diagnosis of renal cell carcinoma (RCC) is challenging and typically
incidental. Currently, several therapeutic strategies are used for the treatment; however, no …

[HTML][HTML] Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation …

L Cheng, A Lopez-Beltran, M Wang, R Montironi… - Modern Pathology, 2021 - Elsevier
Telomerase reverse transcriptase (TERT) promoter mutations have been implicated in
urothelial carcinogenesis and are present in 60–80% of conventional and variants of …

Precursors of urinary bladder cancer: molecular alterations and biomarkers

AS Taylor, AM Acosta, HA Al-Ahmadie, R Mehra - Human Pathology, 2023 - Elsevier
Clinical surveillance and follow-up of patients diagnosed with or at risk for urinary bladder
cancers represent long-term, invasive, and costly processes for which supplemental …

Seltenere Tumoren und Tumortypen des ableitenden Harnsystems in der 5. Aufl. der WHO-Klassifikation 2022

H Reis, H Al-Ahmadie, T Szarvas, V Grünwald… - Die Pathologie, 2024 - Springer
Mit der 5. Aufl. der WHO-Klassifikation der Tumoren der Harnwege und des männlichen
Genitals wurden einige allgemeine und auch speziellen Neuerungen in Struktur …

Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine

E Francini, GN Fanelli, F Pederzoli, S Spisak… - CANCERS, 2022 - arpi.unipi.it
Abstract Simple Summary Early diagnosis of renal cell carcinoma (RCC) is challenging and
typically incidental. Currently, several therapeutic strategies are used for the treatment; …

Upper urinary tract obstruction from cystitis glandularis with intestinal metaplasia, on a background of radical prostatectomy and adjuvant radiation therapy: A case …

A Shen, K Chow, D Gyomber - 2024 - researchsquare.com
Background Cystitis glandularis refers to a metaplastic change in the bladder urothelium. It
is a common phenomenon, and the literature has yet to reach a consensus on whether this …

[HTML][HTML] Pulmonary intestinal adenocarcinoma secondary to intestinal metaplasia of bladder: a rare case report

A Li, Y Yang, P Han - Annals of Palliative Medicine, 2021 - apm.amegroups.org
Intestinal metaplasia (IM) in the esophagus is considered as a risk factor of subsequent
intestinal-type adenocarcinoma based on the classical theory of metaplasia-dysplasia …